img

Global and United States Oral COVID-19 Vaccine Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Oral COVID-19 Vaccine Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and United States Oral COVID-19 Vaccine Market
This report focuses on global and United States Oral COVID-19 Vaccine market, also covers the segmentation data of other regions in regional level and county level.
The global Oral COVID-19 Vaccine revenue was US$ 1200 million in 2024 and is forecast to a readjusted size of US$ 1704 million by 2034 with a CAGR of 5.3% during the forecast period (2024-2034).
In United States the Oral COVID-19 Vaccine revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Oral COVID-19 Vaccine include Pfizer, CanSino Biologics, Kindred Biosciences, Inc., Zhejiang Huahai Pharmaceutical Co.,ltd., Shandong Xinhua Pharmaceutical, Kintor Pharmaceutical and Henan Genuine Biotech Co., Ltd., etc. The global five biggest players hold a share of % in 2024.
Global Oral COVID-19 Vaccine Scope and Market Size
Oral COVID-19 Vaccine market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Oral COVID-19 Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For United States market, this report focuses on the Oral COVID-19 Vaccine market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


Pfizer
CanSino Biologics
Kindred Biosciences, Inc.
Zhejiang Huahai Pharmaceutical Co.,ltd.
Shandong Xinhua Pharmaceutical
Kintor Pharmaceutical
Henan Genuine Biotech Co., Ltd.
Segment by Type
Tablet Type
Inhalable Type

Segment by Application


Adults
Children
Elderly
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Oral COVID-19 Vaccine definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Oral COVID-19 Vaccine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Oral COVID-19 Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral COVID-19 Vaccine sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Oral COVID-19 Vaccine Product Introduction
1.2 Global Oral COVID-19 Vaccine Outlook 2018 VS 2024 VS 2034
1.2.1 Global Oral COVID-19 Vaccine Sales in US$ Million for the Year 2018-2034
1.2.2 Global Oral COVID-19 Vaccine Sales in Volume for the Year 2018-2034
1.3 United States Oral COVID-19 Vaccine Outlook 2018 VS 2024 VS 2034
1.3.1 United States Oral COVID-19 Vaccine Sales in US$ Million for the Year 2018-2034
1.3.2 United States Oral COVID-19 Vaccine Sales in Volume for the Year 2018-2034
1.4 Oral COVID-19 Vaccine Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of United States Oral COVID-19 Vaccine in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Oral COVID-19 Vaccine Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.5 Oral COVID-19 Vaccine Market Dynamics
1.5.1 Oral COVID-19 Vaccine Industry Trends
1.5.2 Oral COVID-19 Vaccine Market Drivers
1.5.3 Oral COVID-19 Vaccine Market Challenges
1.5.4 Oral COVID-19 Vaccine Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Oral COVID-19 Vaccine by Type
2.1 Oral COVID-19 Vaccine Market Segment by Type
2.1.1 Tablet Type
2.1.2 Inhalable Type
2.2 Global Oral COVID-19 Vaccine Market Size by Type
2.2.1 Global Oral COVID-19 Vaccine Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Oral COVID-19 Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Oral COVID-19 Vaccine Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 United States Oral COVID-19 Vaccine Market Size by Type
2.3.1 United States Oral COVID-19 Vaccine Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 United States Oral COVID-19 Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 United States Oral COVID-19 Vaccine Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Oral COVID-19 Vaccine by Application
3.1 Oral COVID-19 Vaccine Market Segment by Application
3.1.1 Adults
3.1.2 Children
3.1.3 Elderly
3.2 Global Oral COVID-19 Vaccine Market Size by Application
3.2.1 Global Oral COVID-19 Vaccine Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Oral COVID-19 Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Oral COVID-19 Vaccine Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 United States Oral COVID-19 Vaccine Market Size by Application
3.3.1 United States Oral COVID-19 Vaccine Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 United States Oral COVID-19 Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 United States Oral COVID-19 Vaccine Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Oral COVID-19 Vaccine Competitor Landscape by Company
4.1 Global Oral COVID-19 Vaccine Market Size by Company
4.1.1 Global Key Manufacturers of Oral COVID-19 Vaccine, Ranked by Revenue (2024)
4.1.2 Global Oral COVID-19 Vaccine Revenue by Manufacturer (2018-2023)
4.1.3 Global Oral COVID-19 Vaccine Sales by Manufacturer (2018-2023)
4.1.4 Global Oral COVID-19 Vaccine Price by Manufacturer (2018-2023)
4.2 Global Oral COVID-19 Vaccine Concentration Ratio (CR)
4.2.1 Oral COVID-19 Vaccine Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Oral COVID-19 Vaccine in 2024
4.2.3 Global Oral COVID-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Oral COVID-19 Vaccine, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Oral COVID-19 Vaccine, Product Offered and Application
4.5 Global Key Manufacturers of Oral COVID-19 Vaccine, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Oral COVID-19 Vaccine Market Size by Company
4.7.1 Key Players of Oral COVID-19 Vaccine in United States, Ranked by Revenue (2024)
4.7.2 United States Oral COVID-19 Vaccine Revenue by Players (2018-2023)
4.7.3 United States Oral COVID-19 Vaccine Sales by Players (2018-2023)
5 Global Oral COVID-19 Vaccine Market Size by Region
5.1 Global Oral COVID-19 Vaccine Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Oral COVID-19 Vaccine Market Size in Volume by Region (2018-2034)
5.2.1 Global Oral COVID-19 Vaccine Sales in Volume by Region: 2018-2023
5.2.2 Global Oral COVID-19 Vaccine Sales in Volume Forecast by Region (2024-2034)
5.3 Global Oral COVID-19 Vaccine Market Size in Value by Region (2018-2034)
5.3.1 Global Oral COVID-19 Vaccine Sales in Value by Region: 2018-2023
5.3.2 Global Oral COVID-19 Vaccine Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Oral COVID-19 Vaccine Market Size YoY Growth 2018-2034
6.2 Americas Oral COVID-19 Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Oral COVID-19 Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Oral COVID-19 Vaccine Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Oral COVID-19 Vaccine Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Oral COVID-19 Vaccine Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Oral COVID-19 Vaccine Market Size YoY Growth 2018-2034
7.2 EMEA Oral COVID-19 Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Oral COVID-19 Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Oral COVID-19 Vaccine Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Oral COVID-19 Vaccine Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Oral COVID-19 Vaccine Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Oral COVID-19 Vaccine Market Size YoY Growth 2018-2034
8.2 China Oral COVID-19 Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Oral COVID-19 Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Oral COVID-19 Vaccine Market Size YoY Growth 2018-2034
9.2 APAC Oral COVID-19 Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Oral COVID-19 Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Oral COVID-19 Vaccine Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Oral COVID-19 Vaccine Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Oral COVID-19 Vaccine Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Description and Business Overview
10.1.3 Pfizer Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Oral COVID-19 Vaccine Products Offered
10.1.5 Pfizer Recent Development
10.2 CanSino Biologics
10.2.1 CanSino Biologics Company Information
10.2.2 CanSino Biologics Description and Business Overview
10.2.3 CanSino Biologics Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 CanSino Biologics Oral COVID-19 Vaccine Products Offered
10.2.5 CanSino Biologics Recent Development
10.3 Kindred Biosciences, Inc.
10.3.1 Kindred Biosciences, Inc. Company Information
10.3.2 Kindred Biosciences, Inc. Description and Business Overview
10.3.3 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Products Offered
10.3.5 Kindred Biosciences, Inc. Recent Development
10.4 Zhejiang Huahai Pharmaceutical Co.,ltd.
10.4.1 Zhejiang Huahai Pharmaceutical Co.,ltd. Company Information
10.4.2 Zhejiang Huahai Pharmaceutical Co.,ltd. Description and Business Overview
10.4.3 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Products Offered
10.4.5 Zhejiang Huahai Pharmaceutical Co.,ltd. Recent Development
10.5 Shandong Xinhua Pharmaceutical
10.5.1 Shandong Xinhua Pharmaceutical Company Information
10.5.2 Shandong Xinhua Pharmaceutical Description and Business Overview
10.5.3 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Products Offered
10.5.5 Shandong Xinhua Pharmaceutical Recent Development
10.6 Kintor Pharmaceutical
10.6.1 Kintor Pharmaceutical Company Information
10.6.2 Kintor Pharmaceutical Description and Business Overview
10.6.3 Kintor Pharmaceutical Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Kintor Pharmaceutical Oral COVID-19 Vaccine Products Offered
10.6.5 Kintor Pharmaceutical Recent Development
10.7 Henan Genuine Biotech Co., Ltd.
10.7.1 Henan Genuine Biotech Co., Ltd. Company Information
10.7.2 Henan Genuine Biotech Co., Ltd. Description and Business Overview
10.7.3 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Products Offered
10.7.5 Henan Genuine Biotech Co., Ltd. Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Oral COVID-19 Vaccine Industry Chain Analysis
11.2 Oral COVID-19 Vaccine Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Oral COVID-19 Vaccine Production Mode & Process
11.4 Oral COVID-19 Vaccine Sales and Marketing
11.4.1 Oral COVID-19 Vaccine Sales Channels
11.4.2 Oral COVID-19 Vaccine Distributors
11.5 Oral COVID-19 Vaccine Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Oral COVID-19 Vaccine CAGR in Value, United States VS Global, 2018 VS 2024 VS 2034
Table 2. Oral COVID-19 Vaccine Market Trends
Table 3. Oral COVID-19 Vaccine Market Drivers
Table 4. Oral COVID-19 Vaccine Market Challenges
Table 5. Oral COVID-19 Vaccine Market Restraints
Table 6. Global Oral COVID-19 Vaccine Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Oral COVID-19 Vaccine Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Oral COVID-19 Vaccine Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Oral COVID-19 Vaccine Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Oral COVID-19 Vaccine, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Oral COVID-19 Vaccine Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Oral COVID-19 Vaccine Revenue Share by Manufacturer, 2018-2023
Table 13. Global Oral COVID-19 Vaccine Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Oral COVID-19 Vaccine Sales Share by Manufacturer, 2018-2023
Table 15. Global Oral COVID-19 Vaccine Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Oral COVID-19 Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Oral COVID-19 Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral COVID-19 Vaccine as of 2024)
Table 18. Global Key Manufacturers of Oral COVID-19 Vaccine, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Oral COVID-19 Vaccine, Product Offered and Application
Table 20. Global Key Manufacturers of Oral COVID-19 Vaccine, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Oral COVID-19 Vaccine in United States, Ranked by Revenue (2024) & (US$ million)
Table 23. United States Oral COVID-19 Vaccine Revenue by Players, (US$ Million), (2018-2023)
Table 24. United States Oral COVID-19 Vaccine Revenue Share by Players, (2018-2023)
Table 25. United States Oral COVID-19 Vaccine Sales by Players, (K Units), (2018-2023)
Table 26. United States Oral COVID-19 Vaccine Sales Share by Players, (2018-2023)
Table 27. Global Oral COVID-19 Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Oral COVID-19 Vaccine Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Oral COVID-19 Vaccine Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Oral COVID-19 Vaccine Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Oral COVID-19 Vaccine Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Oral COVID-19 Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Oral COVID-19 Vaccine Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Oral COVID-19 Vaccine Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Oral COVID-19 Vaccine Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Oral COVID-19 Vaccine Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Oral COVID-19 Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Oral COVID-19 Vaccine Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Oral COVID-19 Vaccine Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Oral COVID-19 Vaccine Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Oral COVID-19 Vaccine Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Oral COVID-19 Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Oral COVID-19 Vaccine Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Oral COVID-19 Vaccine Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Oral COVID-19 Vaccine Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Oral COVID-19 Vaccine Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Pfizer Company Information
Table 48. Pfizer Description and Business Overview
Table 49. Pfizer Oral COVID-19 Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Pfizer Oral COVID-19 Vaccine Product
Table 51. Pfizer Recent Development
Table 52. CanSino Biologics Company Information
Table 53. CanSino Biologics Description and Business Overview
Table 54. CanSino Biologics Oral COVID-19 Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. CanSino Biologics Oral COVID-19 Vaccine Product
Table 56. CanSino Biologics Recent Development
Table 57. Kindred Biosciences, Inc. Company Information
Table 58. Kindred Biosciences, Inc. Description and Business Overview
Table 59. Kindred Biosciences, Inc. Oral COVID-19 Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Kindred Biosciences, Inc. Oral COVID-19 Vaccine Product
Table 61. Kindred Biosciences, Inc. Recent Development
Table 62. Zhejiang Huahai Pharmaceutical Co.,ltd. Company Information
Table 63. Zhejiang Huahai Pharmaceutical Co.,ltd. Description and Business Overview
Table 64. Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Product
Table 66. Zhejiang Huahai Pharmaceutical Co.,ltd. Recent Development
Table 67. Shandong Xinhua Pharmaceutical Company Information
Table 68. Shandong Xinhua Pharmaceutical Description and Business Overview
Table 69. Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Product
Table 71. Shandong Xinhua Pharmaceutical Recent Development
Table 72. Kintor Pharmaceutical Company Information
Table 73. Kintor Pharmaceutical Description and Business Overview
Table 74. Kintor Pharmaceutical Oral COVID-19 Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Kintor Pharmaceutical Oral COVID-19 Vaccine Product
Table 76. Kintor Pharmaceutical Recent Development
Table 77. Henan Genuine Biotech Co., Ltd. Company Information
Table 78. Henan Genuine Biotech Co., Ltd. Description and Business Overview
Table 79. Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Product
Table 81. Henan Genuine Biotech Co., Ltd. Recent Development
Table 82. Key Raw Materials Lists
Table 83. Raw Materials Key Suppliers Lists
Table 84. Oral COVID-19 Vaccine Customers List
Table 85. Oral COVID-19 Vaccine Distributors List
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral COVID-19 Vaccine Product Picture
Figure 2. Global Oral COVID-19 Vaccine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Oral COVID-19 Vaccine Market Size 2018-2034 (US$ Million)
Figure 4. Global Oral COVID-19 Vaccine Sales 2018-2034 (K Units)
Figure 5. United States Oral COVID-19 Vaccine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. United States Oral COVID-19 Vaccine Market Size 2018-2034 (US$ Million)
Figure 7. United States Oral COVID-19 Vaccine Sales 2018-2034 (K Units)
Figure 8. United States Oral COVID-19 Vaccine Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. United States Oral COVID-19 Vaccine Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Oral COVID-19 Vaccine Report Years Considered
Figure 11. Product Picture of Tablet Type
Figure 12. Product Picture of Inhalable Type
Figure 13. Global Oral COVID-19 Vaccine Market Share by Type in 2024 & 2034
Figure 14. Global Oral COVID-19 Vaccine Sales in Value by Type (2018-2034) & (US$ Million)
Figure 15. Global Oral COVID-19 Vaccine Sales Market Share in Value by Type (2018-2034)
Figure 16. Global Oral COVID-19 Vaccine Sales by Type (2018-2034) & (K Units)
Figure 17. Global Oral COVID-19 Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 18. Global Oral COVID-19 Vaccine Price by Type (2018-2034) & (US$/Unit)
Figure 19. United States Oral COVID-19 Vaccine Market Share by Type in 2024 & 2034
Figure 20. United States Oral COVID-19 Vaccine Sales in Value by Type (2018-2034) & (US$ Million)
Figure 21. United States Oral COVID-19 Vaccine Sales Market Share in Value by Type (2018-2034)
Figure 22. United States Oral COVID-19 Vaccine Sales by Type (2018-2034) & (K Units)
Figure 23. United States Oral COVID-19 Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 24. United States Oral COVID-19 Vaccine Price by Type (2018-2034) & (US$/Unit)
Figure 25. Product Picture of Adults
Figure 26. Product Picture of Children
Figure 27. Product Picture of Elderly
Figure 28. Global Oral COVID-19 Vaccine Market Share by Application in 2024 & 2034
Figure 29. Global Oral COVID-19 Vaccine Sales in Value by Application (2018-2034) & (US$ Million)
Figure 30. Global Oral COVID-19 Vaccine Sales Market Share in Value by Application (2018-2034)
Figure 31. Global Oral COVID-19 Vaccine Sales by Application (2018-2034) & (K Units)
Figure 32. Global Oral COVID-19 Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 33. Global Oral COVID-19 Vaccine Price by Application (2018-2034) & (US$/Unit)
Figure 34. United States Oral COVID-19 Vaccine Market Share by Application in 2024 & 2034
Figure 35. United States Oral COVID-19 Vaccine Sales in Value by Application (2018-2034) & (US$ Million)
Figure 36. United States Oral COVID-19 Vaccine Sales Market Share in Value by Application (2018-2034)
Figure 37. United States Oral COVID-19 Vaccine Sales by Application (2018-2034) & (K Units)
Figure 38. United States Oral COVID-19 Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 39. United States Oral COVID-19 Vaccine Price by Application (2018-2034) & (US$/Unit)
Figure 40. Americas Oral COVID-19 Vaccine Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 41. Americas Oral COVID-19 Vaccine Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 42. Americas Oral COVID-19 Vaccine Sales by Type (2018-2034) & (K Units)
Figure 43. Americas Oral COVID-19 Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 44. Americas Oral COVID-19 Vaccine Sales by Application (2018-2034) & (K Units)
Figure 45. Americas Oral COVID-19 Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 46. United States Oral COVID-19 Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 47. Canada Oral COVID-19 Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 48. Mexico Oral COVID-19 Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 49. Brazil Oral COVID-19 Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. EMEA Oral COVID-19 Vaccine Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 51. EMEA Oral COVID-19 Vaccine Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 52. EMEA Oral COVID-19 Vaccine Sales by Type (2018-2034) & (K Units)
Figure 53. EMEA Oral COVID-19 Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 54. EMEA Oral COVID-19 Vaccine Sales by Application (2018-2034) & (K Units)
Figure 55. EMEA Oral COVID-19 Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 56. Europe Oral COVID-19 Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 57. Middle East Oral COVID-19 Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 58. Africa Oral COVID-19 Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 59. China Oral COVID-19 Vaccine Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 60. China Oral COVID-19 Vaccine Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 61. China Oral COVID-19 Vaccine Sales by Type (2018-2034) & (K Units)
Figure 62. China Oral COVID-19 Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 63. China Oral COVID-19 Vaccine Sales by Application (2018-2034) & (K Units)
Figure 64. China Oral COVID-19 Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 65. APAC Oral COVID-19 Vaccine Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 66. APAC Oral COVID-19 Vaccine Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 67. APAC Oral COVID-19 Vaccine Sales by Type (2018-2034) & (K Units)
Figure 68. APAC Oral COVID-19 Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 69. APAC Oral COVID-19 Vaccine Sales by Application (2018-2034) & (K Units)
Figure 70. APAC Oral COVID-19 Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 71. Japan Oral COVID-19 Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 72. South Korea Oral COVID-19 Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 73. China Taiwan Oral COVID-19 Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Oral COVID-19 Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. India Oral COVID-19 Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. Oral COVID-19 Vaccine Value Chain
Figure 77. Oral COVID-19 Vaccine Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed